Literature DB >> 29879521

Reduced transmission of Mycobacterium africanum compared to Mycobacterium tuberculosis in urban West Africa.

Prince Asare1, Adwoa Asante-Poku2, Diana Ahu Prah2, Sonia Borrell3, Stephen Osei-Wusu2, Isaac Darko Otchere2, Audrey Forson4, Gloria Adjapong5, Kwadwo Ansah Koram2, Sebastien Gagneux3, Dorothy Yeboah-Manu6.   

Abstract

OBJECTIVE: Understanding transmission dynamics is useful for tuberculosis (TB) control. A population-based molecular epidemiological study was conducted to determine TB transmission in Ghana.
METHODS: Mycobacterium tuberculosis complex (MTBC) isolates obtained from prospectively sampled pulmonary TB patients between July 2012 and December 2015 were characterized using spoligotyping and standard 15-locus mycobacterial interspersed repetitive unit variable number tandem repeat (MIRU-VNTR) typing for transmission studies.
RESULTS: Out of 2309 MTBC isolates, 1082 (46.9%) unique cases were identified, with 1227 (53.1%) isolates belonging to one of 276 clusters. The recent TB transmission rate was estimated to be 41.2%. Whereas TB strains of lineage 4 belonging to M. tuberculosis showed a high recent transmission rate (44.9%), reduced recent transmission rates were found for lineages of Mycobacterium africanum (lineage 5, 31.8%; lineage 6, 24.7%).
CONCLUSIONS: The study findings indicate high recent TB transmission, suggesting the occurrence of unsuspected outbreaks in Ghana. The observed reduced transmission rate of M. africanum suggests other factor(s) (host/environmental) may be responsible for its continuous presence in West Africa.
Copyright © 2018 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  MIRU-VNTR; Molecular epidemiology; Mycobacterium africanum; Mycobacterium tuberculosis; Spoligotyping; Transmission

Mesh:

Year:  2018        PMID: 29879521      PMCID: PMC6069673          DOI: 10.1016/j.ijid.2018.05.014

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


Introduction

Tuberculosis (TB) is a global health emergency; in 2016 an estimated 10.4 million people got sick, while 1.7 million died of TB (WHO, 2017). In 1993, the World Health Organization (WHO) declared TB a global health emergency and called for more efforts and resources to fight TB. Due largely to the inefficacy of the bacillus Calmette–Guérin (BCG) vaccine against pulmonary TB in adults, the current TB control strategy relies on case detection and treatment under the directly observed therapy short course (DOTs) strategy. The conventional indicators used to assess national control programs under this strategy focus on the proportion of cases that are cured at the end of treatment or whose sputum microscopy becomes negative after the first 2 months of treatment. Such indicators ignore equally important aspects of TB control, which include the duration of infectivity, the frequency of reactivation, and the risk of progression among the infected contacts, as well as the proportion of TB due to recent transmission. Understanding transmission dynamics will contribute to knowledge on factors that enhance the spread of the disease, which is useful for developing preventive interventions. Molecular epidemiological studies have been very useful in a number of countries, identifying populations at risk and areas of high transmission, as well as providing much understanding on the prevalence of different Mycobacterium tuberculosis complex (MTBC) strains with varied virulence and drug resistance rates (Anderson et al., 2014, Malm et al., 2017, Seto et al., 2017, Varghese et al., 2013, Walker et al., 2014, Yang et al., 2016). These studies have shown that the dynamics of TB transmission vary greatly geographically. Even though Africa harbors a large proportion of the global TB cases, with a current incidence of 254 per 100 000 population (WHO, 2017), population-based molecular epidemiological studies needed to understand transmission patterns are rare. The few studies conducted have not been population-based and have lacked an in-depth analysis of the transmission dynamics of MTBC strains belonging to different lineages (Asante-Poku et al., 2016, Glynn et al., 2010, Mulenga et al., 2010). The molecular typing tools – spacer oligonucleotide typing (spoligotyping) and mycobacterial interspersed repetitive unit variable number tandem repeat (MIRU-VNTR) typing – have been used successfully for strain differentiation in TB transmission studies due to their combined high discriminatory power and reproducibility; furthermore, in combination with epidemiological data, they have been used for the detection of recent TB transmission and outbreaks (Anderson et al., 2014, Barnes and Cave, 2003, Maguire et al., 2002, Surie et al., 2017, Varghese et al., 2013). Currently, the high cost and expertise needed for whole genome sequencing and analysis have precluded its use in population-based studies, and considering capacity building in a low-resource setting like Ghana, spoligotyping and MIRU-VNTR typing remain good alternatives. TB in humans is caused mainly by Mycobacterium tuberculosis sensu stricto (MTBss) and Mycobacterium africanum (MAF), which are further divided into seven lineages: MTBss lineages 1–4 and 7 (L1–L4 and L7); MAF lineages 5 and 6 (L5 and L6) (Blouin et al., 2012, de Jong et al., 2010). While MTBss is distributed globally, MAF is restricted to West Africa, where it is responsible for up to 50% of TB cases (Gagneux and Small, 2007). Nevertheless, reports mainly from the Gambia where L6 is prevalent, suggest MAF is attenuated compared to MTBss, hence could be outcompeted by MTBss (de Jong et al., 2010, de Jong et al., 2008, Kallenius et al., 1999). However, an 8-year study recently conducted in Ghana found the prevalence of MAF to be fairly constant at approximately 20%, indicating that MAF and MTBss may be transmitted equally (Yeboah-Manu et al., 2016). The objective of this study was to determine the transmission dynamics of TB caused by MTBss and MAF in Ghana.

Methods

Study design and population

This study was a population-based prospective study in which sputum samples were collected from consecutive clinically diagnosed pulmonary TB patients reporting to 12 selected health facilities within an urban setting (Accra Metropolitan Assembly (AMA)) and the rural setting of East Mamprusi District (MamE) (Supplementary material, Figure S1). The study was conducted from July 2012 to December 2015. A pulmonary TB case was defined as an individual with a case of TB that was confirmed both clinically and bacteriologically. Detailed demographic and epidemiological data were obtained from consented participants.

Mycobacterial isolation, species identification, and drug susceptibility testing

The sputum samples were decontaminated and cultured on Lowenstein–Jensen medium to obtain mycobacterial isolates. These isolates were confirmed as MTBC by detecting the MTBC-specific insertion sequence IS6110 using PCR (Yeboah-Manu et al., 2001). In vitro drug susceptibility to isoniazid and rifampicin were determined using either the microplate Alamar Blue cell viability assay, as described elsewhere (Otchere et al., 2016), and/or the GenoType MTBDRplus assay (Hain Lifescience), following the manufacturer’s protocol (Barnard et al., 2008).

Lineage and strain classification

Lineage and strain classification of the MTBC was achieved in a stepwise manner using large sequence polymorphism typing identifying regions of difference 4, 9, 12, 702, and 711 (de Jong et al., 2010, Gagneux and Small, 2007), single nucleotide polymorphism typing, spoligotyping (Kamerbeek et al., 1997), and MIRU-VNTR typing (Supply et al., 2006). For MIRU-VNTR typing, a customized set of 8 MIRU loci was first used, as described by Asante-Poku et al. (2014), and clustered cases were resolved by analyzing the remaining 7 loci of the standard MIRU-15 loci set (Supply et al., 2006). All assays were well controlled with PCR amplifications and pre-PCR procedures conducted in physically separated compartments to avoid laboratory cross-contamination. The presence of more than one allelic repeat number (multiple allele) for any given locus is suggestive of laboratory cross-contamination, multiple strain infection, or microevolution of a single strain. To prevent bias resulting from cross-contamination and multiple strain infection, isolates with multiple alleles at more than one MIRU locus (described as ‘untypeable’) were excluded from further analysis. Isolates with only one multiple allele at any given locus were, however, included due to the possibility of microevolution. The spoligotyping patterns and assigned shared type numbers obtained were defined according to the SITVITWEB database (http://www.pasteur-guadeloupe.fr: 8081/SITVIT_ONLINE/), while sub-lineages were assigned based on the MIRU-VNTRplus database (http://www.miru-vntrplus.org) (Allix-Beguec et al., 2008). Strains with no lineage nomenclature data were further identified using the TB lineage database (Shabbeer et al., 2012) or otherwise regarded as orphan strains. A strain was defined as an MTBC isolate with a unique molecular signature, and thus a unique spoligotype pattern and/or a unique MIRU-VNTR allelic pattern for the number of investigated MIRU loci.

Clustering analysis and risk factor assessment

Clustering analysis was performed using the categorical parameter and the unweighted pair group method with arithmetic mean (UPGMA) coefficient from a constructed phylogenetic tree using the online MIRU-VNTR tool. Clustering analysis was based on the assumption that strains with the same DNA fingerprint may be epidemiologically linked and associated with recent TB transmission (Hall, 1996). A cluster was defined as two or more isolates (same strain) that share an indistinguishable spoligotype and 15-locus MIRU-VNTR allelic pattern, but allowing for one missing allelic data at any one of the difficult-to-amplify MIRU loci (VNTR 2163, 3690, and 4156). The size of a cluster was also defined using the total number of isolates in the cluster classified into categories of small (2 isolates), medium (3–5 isolates), large (6–20 isolates), and very large (>20 isolates). The recent transmission rate was estimated using the n − 1 formula (Glynn et al., 1999): , where nc is the total number of clustered cases, c is the number of clusters, and n is the total number of cases in the sample. Only one strain per participant was included in the analysis, and follow-up cases were excluded. The clustering analysis was stratified first by location and then by MTBC lineage. The spatial distribution and clustering among all of the observed Spoligo/MIRU strain types were studied by constructing a minimum spanning tree (MST) with Bionumerics software (Applied Maths, Sint-Marteen-Latem, Belgium).

Data management and analysis

Both molecular and epidemiological data were analyzed. Epidemiological data retrieved from all participants with positive MTBC cultures were included in the analysis while excluding data from those with no growth, contaminated cultures, and isolated non-tuberculous mycobacterial species. All statistical analyses were conducted using the Stata statistical package version 14.2 (Stata Corp., College Station, TX, USA). The association of specific lineages and/or sub-lineages of the MTBC with time and/or geographical locations were explored using the Chi-square test and a logistic regression model. For the determination of independent predictive factors for recent TB transmission, a multivariate analysis (forward stepwise approach with a probability entry of 0.1) was conducted using a logistic regression model while estimating the odds ratios (OR). p-Values of <0.05 were considered significant. The study is reported according to the Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID) guidelines (Field et al., 2016).

Results

Characteristics of study participants

A total 3303 sputum smear-positive pulmonary TB cases were recruited, 382 (11.6%) from the rural setting and 2921 (88.4%) from the urban setting; 2604 (78.8%) MTBC isolates were obtained from these cases (Supplementary material, Table S1). After excluding 13 Mycobacterium bovis and isolates that were untypeable (described in the Methods section), 2309 of 2604 isolates (88.7%) were included for clustering analysis. The participants comprised 1631 (71%) males and 663 (29%) females (there was no record of sex for 15 participants) with a median age of 39 years (range 3–91 years) and 33 years (range 4–90 years), respectively (Figure 1; Supplementary material, Table S1). The male-to-female ratio observed was comparable to the national average of approximately 2:1.
Figure 1

Pipeline for recruited participants and culture-positive TB cases included in the clustering analysis.

*Category described as untypeable for MIRU-VNTR includes isolates with ≥2 MIRU loci unamplified (n = 164, 71.3%) and isolates with a double allele at ≥2 MIRU loci (n = 66, 28.7%). These isolates were described as suspected mixed infection or laboratory contamination and hence were excluded from further analysis.

#Frequency was expressed as the total number of Mycobacterium tuberculosis complex (MTBC) isolates obtained.

Pipeline for recruited participants and culture-positive TB cases included in the clustering analysis. *Category described as untypeable for MIRU-VNTR includes isolates with ≥2 MIRU loci unamplified (n = 164, 71.3%) and isolates with a double allele at ≥2 MIRU loci (n = 66, 28.7%). These isolates were described as suspected mixed infection or laboratory contamination and hence were excluded from further analysis. #Frequency was expressed as the total number of Mycobacterium tuberculosis complex (MTBC) isolates obtained. Of the 2309 participants with MTBC genotyping results, 201 (8.7%) were from the rural setting and 2108 (91.3%) from the urban setting. Among this study cohort, 7.4% (184/2482) of participants were previously treated cases including relapse, which is similar to the national value of 7.0% (WHO, 2015). Seventy-one percent (1561/2208) presented with a sputum smear microscopy bacterial burden result of at least 2+ and 33% (544/1665) admitted having contact with at least one TB patient. In a multivariate logistic regression analysis, it was found that male patients were less likely to be infected with a L5 strain (adjusted OR 0.7, 95% confidence interval (CI) 0.5–0.9) and individuals living in villages were more likely to be infected with a L6 strain (OR 6.6, 95% CI 1.2–36.1) (Supplementary material, Table S2).

Population structure and recent transmission rate estimation

Among the 2309 MTBC isolates analyzed for clustering, 1870 (81.0%) were MTBss and 439 (19.0%) were MAF. Six of the seven human-adapted MTBC lineages were found, with L4, L5, and L6 being most frequent: 1741 (75.4%), 289 (12.5%), and 150 (6.5%) isolates, respectively (Table 1). The relative proportions of the most frequent MTBC lineages remained constant over the entire 3.5-year study period (ptrend: L4 p = 0.72, L5 p = 0.84, L6 p = 0.25; Figure 2).
Table 1

Geographical distribution and population structure of MTBC in Ghana by spoligotyping.

Rural, n (%)Urban, n (%)Combined, n (%)a
MTBC isolates204 (8.8)2118 (91.2)2322
Species distribution
 M. tuberculosis172 (9.2)1698 (90.8)1870 (80.5)
 M. africanum29 (6.6)410 (93.4)439 (18.9)
 Animal3 (23.1)10 (76.9)13 (0.6)



Human adapted MTBC lineage distribution
 Lineage_14 (10.5)34 (89.5)38 (1.6)
 Lineage_214 (21.5)51 (78.5)65 (2.8)
 Lineage_31 (3.8)25 (96.2)26 (1.1)
 Lineage_4153 (8.8)1588 (91.2)1741 (75.4)
 Lineage_515 (5.2)274 (94.8)289 (12.5)
 Lineage_614 (9.3)136 (90.7)150 (6.5)



Lineage_4 sub-lineage distribution
 Cameroon77 (7.4)969 (92.6)1046 (60.1)
 Ghana50 (13.3)326 (86.7)376 (21.6)
 Haarlem12 (7.7)144 (92.3)156 (9.0)
 LAM7 (14.0)43 (86.0)50 (2.9)
 Uganda1 (2.5)39 (97.5)40 (2.3)
 Other (S, U, X, NEW-1)5 (9.8)46 (90.2)51 (2.9)
 Not determined1 (4.5)21 (95.5)22 (1.3)

MTBC, Mycobacterium tuberculosis complex.

Proportions stated here are column-wise distributions with respect to the categories of species, lineages or sub-lineages.

Figure 2

Temporal distribution of 2309 Mycobacterium tuberculosis complex (MTBC) isolates stratified by lineage. Lineages are color-coded with the universally accepted color codes for the main MTBC lineages.

Temporal distribution of 2309 Mycobacterium tuberculosis complex (MTBC) isolates stratified by lineage. Lineages are color-coded with the universally accepted color codes for the main MTBC lineages. Geographical distribution and population structure of MTBC in Ghana by spoligotyping. MTBC, Mycobacterium tuberculosis complex. Proportions stated here are column-wise distributions with respect to the categories of species, lineages or sub-lineages. Of the 2309 isolates included for clustering analysis, 1227 (53.1%) isolates clustered in 276 different clusters with a mean cluster size of 4 (range 2–35) and 1082 (46.9%) unique isolates were identified, giving a total of at least 1358 different MTBC strains circulating within the study population (Table 2a). Using the n − 1 method, the overall clustering rate (reflecting the recent transmission rate) was estimated to be 41.2%. Lineages 2, 4, and 5 contributed high clustering rates of 53.8%, 44.9%, and 31.8%, respectively (Table 2a). The Cameroon, Ghana, and Haarlem sub-lineages of L4 were the most abundant sub-lineages and, compared to the LAM sub-lineage, contributed significantly to the observed high L4 clustering rate (p < 0.05) (Figure 3). There was no significant difference in the clustering rate between the Cameroon and Ghana sub-lineages (p = 0.57) (Figure 3). While no significant difference in the recent transmission rates was seen between members of MAF (L5 and L6, p = 0.118), it was found that L4 was transmitted significantly more (p < 0.001), with seven of its clusters having very large cluster sizes (>20 isolates per cluster) made up of the Ghana sub-lineage (four very large clusters) and Cameroon sub-lineage (three very large clusters) (Figure 3; Supplementary material, Figure S2). Notwithstanding the lower transmissibility of L5 and L6 compared to L4, four large clusters were also observed for each of these lineages. The urban and rural settings had estimated recent transmission rates of 41.7% and 9.0%, respectively.
Table 2a

Clustering analysis stratified by lineages and major sub-lineage populations of MTBC.

LineageIsolates (n)Clustered cases (c)Clustered strains (nc)Single cases (s)Total strain types (s + c)Clustering ratea (%)
Lineage 13837313410.5
Lineage 265843223053.8
Lineage 3262422247.7
Lineage 4174120198275996044.9
Cameroonb104612361443255546.9
Ghanab3763620617020645.2
Haarlemb1562391658843.6
LAMb50625253138.0
Ugandab40516242927.5
Lineage 52895114314619731.8
Lineage 6150114810211324.7
Summaryc230927612271082135841.2

MTBC, Mycobacterium tuberculosis complex.

The clustering rate was used to estimate the recent transmission rate.

Major lineage 4 sub-population.

The summary was calculated using only the items in cells corresponding to the six main lineages.

Figure 3

Cluster distribution and size stratified by lineage (panel A and C) and sub-lineage (panel B and D). *p < 0.001, #p = 0.118, ¤p = 0.565.

Cluster distribution and size stratified by lineage (panel A and C) and sub-lineage (panel B and D). *p < 0.001, #p = 0.118, ¤p = 0.565. Clustering analysis stratified by lineages and major sub-lineage populations of MTBC. MTBC, Mycobacterium tuberculosis complex. The clustering rate was used to estimate the recent transmission rate. Major lineage 4 sub-population. The summary was calculated using only the items in cells corresponding to the six main lineages.

Exploring the diversity and clustering within the MTBC lineages

Very large molecular clusters (clusters with >20 isolates; defined in the Methods section) were observed for L4, in addition to one strikingly large cluster belonging to the Beijing family of lineage 2 (Figure 4; Supplementary material, Figure S3). Generally, only a few multidrug-resistant MTBC strains were observed across all the major lineages (Supplementary material, Figures S4–S6). There was no single large cluster with all isolates being multidrug-resistant (Supplementary material, Figure S4). The spatial distributions of the isolates constituting each cluster stratified by study setting are shown in the Supplementary material, Figures S7–S9.
Figure 4

Minimum spanning tree (MST) representation of the clustering of 2322 Mycobacterium tuberculosis complex (MTBC) isolates from Accra Metropolitan Assembly and East Mamprusi District built with Bionumerics software. The color code reflects the main MTBC lineages 1 to 6 with the size depicting the number of clustered isolates with an identical strain type.

Minimum spanning tree (MST) representation of the clustering of 2322 Mycobacterium tuberculosis complex (MTBC) isolates from Accra Metropolitan Assembly and East Mamprusi District built with Bionumerics software. The color code reflects the main MTBC lineages 1 to 6 with the size depicting the number of clustered isolates with an identical strain type.

Molecular epidemiology and factors associated with clustering: logistic regression modeling

Risk factors associated with recent TB transmission were sought. A total of 675 individuals belonging to either large (6–20 isolates) or very large (>20 isolates) molecular clusters were identified, with a combined median cluster size of 14 (range 6–35). The majority of the individuals belonging to very large clusters were male, with a male-to-female ratio of approximately 3:1, significantly higher than the 2:1 ratio observed in the general TB patient population (p = 0.022). Three large clusters – cluster ID MSC4193, MSC5003.X, and MSC4107, with cluster sizes of 9, 7, and 7 respectively – involved only male subjects (Table 3).
Table 3

Characteristics of large molecular clusters resulting from combined 15-MIRU and spoligotyping cluster analysis.

NumberCluster codeaNumber of cases in clusterSex, male: femaleMedian age (IQR)Diagnosis lapseb (months)Same residential districtcKnown risk factor (number)dLineage (sub-lineage)Drug resistancee
1MSC4063.X3531:434 (26–44)407/5/5/4/4/5Smoking (6)Other (8)L4 (Cameroon)3
2MSC4060.X3424:1034 (25–45)416/4/3/3/3/3Smoking (6)Other (5)L4 (Cameroon)4
3MSC4045.X3026:440 (29–48)397/3/3/3/3Smoking (5)HIV (4)Other (3)L4 (Cameroon)2
4MSC20012722:535 (27–48)378/5Smoking (8)HIV (4)Other (2)L2 (Beijing)1
5MSC40312619:741 (33–52)366/4/3Smoking (6)HIV (3)Other (1)L4 (Ghana)11
6MSC41102621:538 (28–51)396/3Smoking (5)HIV (1)Other (4)L4 (Ghana)ND
7MSC40952416:835 (24–45)397/6Smoking (5)Other (2)L4 (Ghana)9
8MSC40272116:527 (25–45)406/3Smoking (3)L4 (Ghana)3
9MSC4063.31918:128 (21–45)415/5Smoking (7)L4 (Cameroon)ND
10MSC4063.181810:735 (24–41)366/3Smoking (4)HIV (1)L4 (Cameroon)ND
11MSC40131513:242 (32–55)324/3Smoking (3)HIV (2)Other (2)L4 (Haarlem)2
12MSC41361513:236 (28–44)346Smoking (2)HIV (1)Other (3)L4 (Haarlem)ND
13MSC4040148:631 (27–45)333/3HIV (1)Other (4)L4 (Cameroon)1
14MSC4069.X1411:327 (23–38)346/3Smoking (2)HIV (2)Other (1)L4 (Cameroon)ND
15MSC4073149:540 (29–47)245/4Smoking (3)L4 (Cameroon)3
16MSC5002.X147:740 (38–53)285HIV (2)Smoking (1)L5 (West African I)2
17MSC4063.2138:437 (27–44)384Smoking (2)Other (3)L4 (Cameroon)ND
18MSC4068.X139:435 (30–44)275/3Smoking (6)HIV (2)Other (2)L4 (Cameroon)ND
19MSC4024126:528 (26–42)373Smoking (2)Other (1)L4 (X3)4
20MSC4060.18127:535 (32–40)363/3Smoking (2)HIV (2)Other (3)L4 (Cameroon)1
21MSC4063.17127:526 (24–51)39NDSmoking (4)HIV (1)Other (3)L4 (Cameroon)2
22MSC4138117:441 (30–48)284Smoking (4)L4 (LAM)ND
23MSC4069.3105:532 (24–39)313Smoking (1)HIV (1)L4 (Cameroon)2
24MSC4104107:235 (25–54)345Smoking (3)Other (1)L4 (Ghana)6
25MSC6006104:641 (35–47)335/3Smoking (1)Other (2)L6 (West African II)ND
26MSC4045.397:243 (32–50)333Smoking (1)Other (1)L4 (Cameroon)1
27MSC4060.2196:332 (26–43)22NDHIV (1)Other (2)L4 (Cameroon)ND
28MSC4060.395:432 (25–53)343Smoking (1)Other (2)L4 (Cameroon)ND
29MSC419399:036 (30–41)28NDSmoking (6)HIV (1)Other (2)L4 (Cameroon)ND
30MSC4068.386:245 (34–54)272Smoking (2)HIV (1)Other (1)L4 (Cameroon)ND
31MSC402276:150 (46–62)364Smoking (1)Other (1)L4 (Haarlem)ND
32MSC4060.473:434 (30–49)225Smoking (1)L4 (Cameroon)ND
33MSC4080.1374:324 (17–50)203Smoking (1)L4 (Cameroon)1
34MSC408276:135 (28–40)333Smoking (1)L4 (Ghana)ND
35MSC410777:038 (29–53)283/3Smoking (2)Other (1)L4 (Ghana)1
36MSC5003.274:335 (26–57)33NDHIV (1)L5 (West African I)1
37MSC5003.X77:043 (26–66)343Smoking (2)Other (1)L5 (West African I)ND
38MSC600475:244 (36–50)31NDHIV (1)Other (3)L6 (West African II)3

MIRU, mycobacterial interspersed repetitive unit; L2, lineage 2; L4, lineage 4; L5, lineage 5; L6, lineage 6; ND, none determined; IQR, interquartile range.

Cluster codes in bold font involved evidence of household transmission.

Time lapse (in months) between first diagnosed case and last diagnosed case.

Number of participants with the same district of residence. Only >2 individuals in the same residential district are indicated. ‘/’ is used to separate individuals from different districts.

‘Other’ in this category refers to alcohol or substance abuse.

Number of participants carrying strains with drug resistance to either isoniazid or rifampicin.

Clustering analysis stratified by study setting and lineages/major sub-lineage populations of MTBC. MTBC, Mycobacterium tuberculosis complex. The clustering rate was used to estimate the recent transmission rate. Major lineage 4 sub-population. The summary was calculated using only the items in cells corresponding to the six main lineages. Characteristics of large molecular clusters resulting from combined 15-MIRU and spoligotyping cluster analysis. MIRU, mycobacterial interspersed repetitive unit; L2, lineage 2; L4, lineage 4; L5, lineage 5; L6, lineage 6; ND, none determined; IQR, interquartile range. Cluster codes in bold font involved evidence of household transmission. Time lapse (in months) between first diagnosed case and last diagnosed case. Number of participants with the same district of residence. Only >2 individuals in the same residential district are indicated. ‘/’ is used to separate individuals from different districts. ‘Other’ in this category refers to alcohol or substance abuse. Number of participants carrying strains with drug resistance to either isoniazid or rifampicin. Epidemiological investigations revealed both localized and dispersed recent transmission among the clustered cases, with suggested evidence of household transmission in at least six large clusters (MSC4063.X, MSC2001, MSC4095, MSC4063.18, MSC4069.X, and MSC4104). Specifically, the same L4 strain (part of cluster MSC4069.X) was found among three individuals belonging to the same household, with the oldest person (age 49 years) reporting having contact with his son who had TB 4 months prior to his episode (suggestive of household transmission). The majority of the large clusters involved TB strains circulating over almost the entire study period (Supplementary material, Figure S10). Apart from three Ghana sub-lineage clusters (MSC4104, MSC4031, and MSC4095) and one L6 cluster (MSC6004), with respectively 60% (6/10), 42% (11/26), 38% (9/24), and 43% (3/7) of isolates showing resistance to rifampicin and/or isoniazid (Table 3), such high levels of drug resistance were not observed in the other large and very large clusters. Only 2% of the isolates belonging to large and very large clusters were multidrug-resistant TB strains and this was significantly lower than that for small (2 isolates) and medium (3–5 isolates) (4%) clusters (p = 0.031). For the determination of possible factors associated with recent TB transmission, a general logistic regression model including all MTBC lineages was first performed, using the event of belonging to a clustered case as the outcome variable and participant variables as possible predictors (Table 4). In a separate logistic regression model, risk factors associated with recent TB transmission were tested stratified independently by L4 and L5 (Table 5), excluding L6 due to the limited sample size. In the multivariable analysis for the general logistic regression model, it was found that harboring either an isoniazid- or rifampicin-resistant MTBC strain (adjusted OR 0.7, 95% CI 0.5–0.9) was associated with a lower odds of belonging to a clustered case (Table 4). All other factors such as education status, occupation, income level, ethnicity, religion, and HIV status had no association with recent TB transmission.
Table 4

Logistic regression analysis of risk factors associated with TB clustering (recent TB transmission).

VariableMTBC (N = 2309)
Univariate
Multivariatea
Total TB cases, n (%)Clustered casesb, n (%)OR (95% CI)p-ValueAdjusted OR (95% CI)p-Value
Year diagnosed2309 (100)1229 (53·2)
 2012244 (10·6)147 (60·3)1·4 (1·0–1·8)0·0431·3 (0·9–1·7)0·113
 2013776 (33·6)410 (52·8)Reference
 2014707 (30·6)365 (51·6)1·0 (0·8–1·2)0·6420·9 (0·7–1·1)0·203
 2015582 (25·2)307(52·8)1·0 (0·8–1·2)0·9751·0 (0·8–1·2)0·703



Sex2294 (99·4)
 Male1631 (71·1)863 (52·9)1·0 (0·8–1·2)0·685
 Female663 (28·9)357 (53·8)Reference



Age (years)c2224 (96·3)
 <1537 (1·7)25 (67·6)1·6 (0·8–3·3)0·1831·6 (0·8–3·2)0·221
 15–29639 (28·7)360 (56·3)Reference
 30–39570 (25·6)307 (53·9)0·9 (0·7–1·1)0·3870·9 (0·7–1·2)0·688
 40–59778 (35·0)398 (51·2)0·8 (0·7–1·0)0·0520·9 (0·7–1·1)0·241
 >59200 (9·0)97 (48·5)0·7 (0·5–1·0)0·0530·9 (0·6–1·1)0·211



Nationality1781 (77·1)
 Ghanaian1714 (96·2)932 (54·4)Reference
 Other67 (3·8)38 (56·7)1·1 (0·7–1·8)0·706
Locality2309 (100)1229 (53·2)
 Rural201 (8·7)74 (36·8)Reference
 Urban2108 (91·3)1155 (54·8)2·1 (1·5–2·8)<0·001



Residence classification1642 (71·1)
 Village69 (4·2)27 (39·1)0·5 (0·3–0·8)0·007
 Town182 (11·1)96 (52·7)0·9 (0·6–1·2)0·415



City residential area52 (3·2)27 (51·9)0·8 (0·5–1·5)0·564
 City suburb1136 (69·2)636 (56·0)Reference
 City slum203 (12·4)112 (55·2)1·0 (0·7–1·3)0·83



Residential district1538 (66·6)
 Ablekuma545 (35·4)298 (54·7)Reference
 Ashiedu Keteke170 (11·1)100 (58·8)1·2 (0·8–1·7)0·343
 Ayawaso220 (14·3)124 (56·4)1·1 (0·8 to 1·5)0·672
 Kpeshie224(14·6)121 (54·0)1·0 (0·7–1·3)0·867
 Mamprusi East70 (4·6)22 (31·4)0·4 (0·2–0·6)<0·001
 Okaikoi176 (11·4)98 (55·7)1·0 (0·7 to 1·5)0·816
 Osu Klottey133 (8·6)78 (58·7)1·2 (0·8–1·7)0·409



Household type1624 (70·3)
 Self-contained412 (25·4)221 (53·6)1·0 (0·8–1·2)0·797
 Compound house1212 (74·6)659 (54·4)Reference



Education1748 (75·7)
 Primary222 (12·7)125 (56·3)1·1 (0·8–1·5)0·637
 Middle/JHS637 (36·4)347 (54·5)Reference
 Secondary429 (24·5)232 (54·1)1·0 (0·8–1·3)0·899
 Tertiary190 (10·9)110 (57·9)1·1 (0·8–1·6)0·405
 No education270 (15·4)141 (52·2)0·9 (0·7–1·2)0·534



Occupation1722 (74·6)
 Unemployed390 (22·6)208 (53·3)0·9 (0·7–1·1)0·423
 Unskilled951 (55·2)530 (55·7)Reference
 Skilled381 (22·1)198 (52·0)0·9 (0·7–1·1)0·213



Monthly income (GH¢)1622 (70·2)
 None371 (22·9)213 (57·4)Reference
 <301807 (49·7)438 (54·3)0·9 (0·7–1·1)0·315
 301–1000407 (25·1)218 (53·6)0·8 (0·6–1·1)0·281
 >100037 (2·3)15 (40·5)0·5 (0·3–1·0)0·052



Religion1771 (76·7)
 Christian1361 (76·9)739 (54·3)Reference
 Islam302 (17·0)161 (53·3)1·0 (0·7–1·2)0·755
 Other26 (1·5)14 (53·9)1·0 (0·4–2·1)0·963
 Not religious82 (4·6)49 (59·7)1·2 (0·8–2·00·366



Ethnicity1760 (76·4)
 Akan570 (32·3)309 (54·2)Reference
 Ewe259 (14·7)143 (55·2)1·0 (0·8–1·4)0·788
 Ga/Adangbe544 (30·8)310 (57·0)1·1 (0·9–1·4)0·352
 Other392 (22·2)196 (50·0)0·8 (0·6–1·1)0·199



Marital status1758 (76·1)
 Single766 (43·6)431 (56·3)Reference
 Married742 (42·2)395 (53·2)0·9 (0·7–1·1)0·237
 Divorced167 (9·5)99 (59·3)1·1 (0·8–1·6)0·476
 Widowed83 (4·7)35 (42·2)0·6 (0·3–0·9)0·015



Smear positivity2208 (95·6)
 Scanty 1–9173 (7·8)96 (55·5)1·1 (0·8–1·5)0·714
 1+474 (21·5)237 (50·0)0·9 (0·7–1·1)0·151
 2+546 (24·7)294 (53·9)1·0 (0·8–1·2)0·957
 3+1015 (46·0)548 (54·0)Reference



Previous TB treatment1737 (75·2)
 Yes291 (16·8)153 (52·6)0·9 (0·7–1·2)0·535
 No1446 (83·2)789 (54·6)Reference



Risk of TB contact
 Close friend/household1665 (72·1)
 No contact1121 (67·3)594 (53·0)Reference
 1 contact212 (12·7)118 (55·7)1·1 (0·8–1·5)0·475
 2–5 contacts309 (18·6)179 (57·9)1·2 (0·9–1·6)0·123
 6–10 contacts23 (1·4)15 (65·2)1·7 (0·7–4·0)0·249



Imprisonment1660 (71·9)
 Yes97 (5·8)56 (57·7)1·1 (0·8–1·7)0·513
 No1563 (94·2)849 (54·3)Reference



Health/laboratory worker1661 (71·9)
 Yes47 (2·8)25 (53·2)0·9 (0·5–1·7)0·85
 No1614 (97·2)881 (54·6)Reference



Immunosuppressive condition1695 (73·4)
 Any893 (52·7)488 (54·6)1·0 (0·9–1·2)0·747
 None802 (47·3)432 (53·9)Reference



Diabetes mellitus534 (23·1)
 Yes104 (19·5)54 (51·9)1·0 (0·7–1·5)0·957
 No430 (80·5)222 (51·6)Reference



HIV status1166 (50·5)
Positive144 (12·3)82 (56·9)1·1 (0·8–1·6)0·481
 Negative1022 (87·7)550 (53·8)Reference



Smoking1518 (65·7)
 Yes434 (28·6)237 (54·6)1·0 (0·8–1·2)0·949
 No1084 (71·4)590 (54·4)Reference



Substance abuse (excluding alcohol)1401 (60·7)
 Yes140 (10·0)84 (60·0)1·3 (0·9–1·8)0·172
 No1261 (90·0)680 (53·9)Reference



Substance abuse (including alcohol)1474 (63·8)
 Yes460 (31·2)250 (54·3)1·0 (0·8–1·3)0·858
 No1014 (68·8)546 (53·8)Reference



Lineage2309 (100)
 Lineage 138 (1·7)7 (18·4)0·2 (0·08–0·4)<0·0010·13 (0·05–0·36)<0·001
 Lineage 265 (2·8)43 (66·2)1·5 (0·9–2·5)0·1261·5 (0·9–2·5)0·155
 Lineage 326 (1·1)4 (15·4)0·1 (0·05–0·4)<0·0010·15 (0·05–0·45)0·001
 Lineage 41741 (75·4)984 (56·5)Reference
 Lineage 5289 (12·5)143 (49·5)0·8 (0·6–1·0)0·0260·7 (0·6–0·9)0·032
 Lineage 6150 (6·5)48 (32·0)0·4 (0·3–0·5)<0·0010·3 (0·2–0·5)<0·001



Lineage 4 sub-lineage
 Cameroon1046 (60·1)616 (58·9)Reference
 Ghana376 (21·6)206 (54·8)0·8 (0·7–1·1)0·167
 Haarlem156 (9·0)91(58·3)1·0 (0·7–1·4)0·895
 LAM50 (2·9)25 (50·0)0·7 (0·4–1·2)0·215
 Uganda40 (2·3)16 (40·0)0·5 (0·2–0·9)0·02
 Other51 (2·9)26 (51·0)0·7 (0·4–1·3)0·265
 Not determined22 (1·3)4 (18·2)0·2 (0·1–0·5)0·001



Drug resistance2300 (99·6)
 Any313 (13·6)138 (44·1)0·6 (0·5–0·8)<0·0010·7 (0·5–0·9)0·002
 None1987 (86·4)1090 (54·9)Reference



Isoniazid mono-resistant2300 (99·6)
 Yes295 (12·8)129 (43·7)0·6 (0·5–0·8)<0·001
 No2005 (87·2)1099 (54·8)Reference



Multidrug resistant (MDR)2300 (99·6)
 Yes81 (3·5)35 (43·2)0·7 (0·4–1·0)0·063
 No2219 (96·5)1193 (53·8)Reference



Cluster size (n)1227 (53·1)
 Small (2)290 (23·6)
 Medium (3–5)262 (21·4)
 Large (6–20)452 (36·8)
 Very large (>20)223 (18·2)

MTBC, Mycobacterium tuberculosis complex; TB, tuberculosis; OR, odds ratio; CI, confidence interval; JHS, junior high school; GH, Ghanaian cedi.

For the multivariate model, only variables with p < 0.1 and with at least 90% of available data were included. However ‘locality’ was excluded due to the small sample size from the rural setting. Residence classification, marital status, isoniazid mono-resistance, and MDR were excluded due to collinearity with other variables in the model.

A cluster was defined as two or more isolates (same strain) that share an indistinguishable spoligotype and 15-locus MIRU-VNTR allelic pattern, but allowing for one missing allelic data at any one of the difficult-to-amplify MIRU loci.

A significant decreasing trend in the probability of belonging to a clustered case was found with increasing age category (p = 0.004).

Table 5

Risk factors associated with TB clustering: logistic regression analysis stratified by lineage.a

VariablesLineage 4 (n = 1741)
UnivariateMultivariateb
Lineage 5 (n = 289)
Univariate
TB cases, n (%)Clustered casesc, n (%)OR (95% CI)Adjusted OR (95% CI)p-ValueTB cases, n (%)Clustered casesc, n (%)OR (95% CI)p-Value
Year diagnosed1741 (100)289 (100)
 2012183 (10·5)120 (65·6)1·5 (1·1–2·1)*1·4 (1·0–2·1)0·06226 (9·0)14 (53·8)1·2 (0·5–2·9)0·659
 2013568 (32·6)318 (56·0)Reference98 (33·9)48 (49·0)Reference
 2014548 (31·5)300 (54·7)1·0 (0·8–1·2)1·0 (0·7–1·3)0·84792 (31·8)43 (46·7)0·9 (0·5–1·6)0·757
 2015442 (25·4)244 (55·2)1·0 (0·8–1·2)1·0 (0·7–1·3)0·95573 (25·3)38 (52·1)1·2 (0·6–2·1)0·691



Age (years)1672283
 <1527 (1·6)20 (74·1)2·1 (0·9–5·0)5 (1·8)3 (60·0)
 15–29497 (29·7)289 (58·2)Reference78 (27·6)42 (53·8)
 30–39432 (25·8)252 (58·3)1·0 (0·8–1·3)68 (24·0)31 (45·6)
 40–59580 (34·7)315 (54·3)0·9 (0·7–1·1)94 (33·2)48 (51·1)
 >59136 (8·1)71 (52·2)0·8 (0·5–1·2)38 (13·4)16 (42·1)



Locality1741 (100)289 (100)
 Rural153 (8·8)59 (38·6)Reference15 (5·2)4 (26·7)Reference
 Urban1588 (91·2)923 (58·1)2·2 (1·6–3·1)**274 (94·8)139 (50·7)2·8 (0·9–9·1)0·081



Residential district1165189
 Ablekuma412 (35·4)237 (57·5)Reference77 (40·7)39 (50·7)Reference
 Ashiedu Keteke132 (11·3)81 (61·4)1·2 (0·8–1·8)13 (6·9)5 (38·5)0·6 (0·2–2·0)0·419
 Ayawaso178 (15·3)111 (62·4)1·2 (0·8–1·8)21 (11·1)7 (33·3)0·5 (0·2–1·4)0·163
 Kpeshie166 (14·2)88 (53·0)0·8 (0·6–1·2)37 (19·6)25 (67·6)2·0 (0·9–4·6)0·091
 Mamprusi East56 (4·8)19 (33·9)0·4 (0·2–0·7)*4 (2·1)1 (25·0)0·32 (0·03–3·26)0·339
 Okaikoi134 (11·5)80 (59·7)1·1 (0·7–1·6)24 (12·7)12 (50·0)1·0 (0·4–2·4)0·956
 Osu Klottey87 (7·5)58 (66·7)1·5 (0·9–2·4)13 (6·9)5 (38·5)0·6 (0·2–2·0)0·419



Monthly income (GH¢)1222
 None275 (22·5)167 (60·7)Reference
 <301605 (49·5)351 (58·0)0·9 (0·7–1·2)
 301–1000314 (25·7)184 (58·6)0·9 (0·7–1·3)
 >100028 (2·3)11 (39·3)0·4 (0·2–0·9)*



Marital status1322
 Single591 (44·7)355 (60·1)Reference
 Married549 (41·5)312 (56·8)0·9 (0·7–1·1)0·9 (0·7–1·2)0·589
 Divorced124 (9·4)78 (62·9)1·1 (0·8–1·7)1·1 (0·7–1·7)0·543
 Widowed58 (4·4)24 (41·4)0·5 (0·3–0·8)*0·5 (0·3–0·8)0·011



Lineage 4 sub-lineage
 Cameroon1046 (60·1)614 (58·7)
 Ghana376 (21·6)206 (54·8)0·9 (0·7–1·1)0·9 (0·7–1·2)0·403
 Haarlem156 (9·0)91 (58·3)1·0 (0·7–1·4)1·0 (0·7–1·5)0·87
 LAM50 (2·9)25 (50·0)0·7 (0·4–1·2)0·7 (0·4–1·4)0·354
 Uganda40 (2·3)16 (40·0)0·5 (0·2–0·9)*0·4 (0·2–0·8)0·013
 Other51 (2·9)26 (51·0)0·7 (0·4–1·3)0·8 (0·4–1·6)0·558
 Not determined22 (1·3)4 (18·2)0·2 (0·1–0·5)*0·10 (0·03–0·35)<0·001



Drug resistance1736
 Any241 (13·9)114 (47·3)0·7 (0·5–0·9)*0·7 (0·5–1·0)0·059
 None1495 (86·1)867 (58·0)Reference

TB, tuberculosis; OR, odds ratio; CI, confidence interval; GH, Ghanaian cedi.

Only variables with p < 0.1 from the general logistic regression model in Table 4 were included in this analysis. *p < 0.05; **p < 0.001.

For the multivariate model, only variables with p < 0.1 and with at least 90% of available data were included.

A cluster was defined as two or more isolates (same strain) that share an indistinguishable spoligotype and 15-locus MIRU-VNTR allelic pattern, but allowing for one missing allelic data at any one of the difficult-to-amplify MIRU loci.

Logistic regression analysis of risk factors associated with TB clustering (recent TB transmission). MTBC, Mycobacterium tuberculosis complex; TB, tuberculosis; OR, odds ratio; CI, confidence interval; JHS, junior high school; GH, Ghanaian cedi. For the multivariate model, only variables with p < 0.1 and with at least 90% of available data were included. However ‘locality’ was excluded due to the small sample size from the rural setting. Residence classification, marital status, isoniazid mono-resistance, and MDR were excluded due to collinearity with other variables in the model. A cluster was defined as two or more isolates (same strain) that share an indistinguishable spoligotype and 15-locus MIRU-VNTR allelic pattern, but allowing for one missing allelic data at any one of the difficult-to-amplify MIRU loci. A significant decreasing trend in the probability of belonging to a clustered case was found with increasing age category (p = 0.004). Risk factors associated with TB clustering: logistic regression analysis stratified by lineage.a TB, tuberculosis; OR, odds ratio; CI, confidence interval; GH, Ghanaian cedi. Only variables with p < 0.1 from the general logistic regression model in Table 4 were included in this analysis. *p < 0.05; **p < 0.001. For the multivariate model, only variables with p < 0.1 and with at least 90% of available data were included. A cluster was defined as two or more isolates (same strain) that share an indistinguishable spoligotype and 15-locus MIRU-VNTR allelic pattern, but allowing for one missing allelic data at any one of the difficult-to-amplify MIRU loci. Finally, using adjusted predictions, it was found that the probability of belonging to a clustered case decreased with age and increased with the number of TB contacts (Figure 5). In a separate logistic regression analysis, including age as a continuous variable with belonging to a clustered case as the outcome variable, it was found that each year increase in age was significantly associated with an approximately 1% (95% CI 0.13–2.00%) decrease in the odds of a TB patient being part of a recent transmission event (p = 0.007).
Figure 5

Adjusted predictions of the probability of belonging to a clustered case with 95% confidence interval: (A) at the year of diagnosis, (B) while ageing, (C) considering the number of close TB contact(s), and (D) considering the number of circulating Mycobacterium tuberculosis complex (MTBC) lineages.

Adjusted predictions of the probability of belonging to a clustered case with 95% confidence interval: (A) at the year of diagnosis, (B) while ageing, (C) considering the number of close TB contact(s), and (D) considering the number of circulating Mycobacterium tuberculosis complex (MTBC) lineages.

Discussion

The aims of this study were to conduct a population-based prospective molecular epidemiological study to analyze the transmission dynamics of MTBC strains circulating in Ghana and to identify risk factors associated with recent TB transmission. A high MTBC isolate recovery rate of 78.8% was obtained, higher than that reported in similar studies (Hamblion et al., 2016, Mears et al., 2015) and this strengthens the power of the sample size to make assessments of the TB transmission rate in Ghana. This study identified a high TB clustering (recent TB transmission) rate of 41.2%, which is quite alarming, with the urban and rural areas having estimated rates of 41.7% and 9.0%, respectively (Table 2b). These findings call for intensifying community outreach programs to encourage early case reporting and infection control. Moreover, the analysis predicted the probability of clustering to generally increase with the increase in the number of TB contacts (Figure 5). This means that a susceptible individual is likely to have TB and be involved in a recently transmitted event as the number of TB contacts increases.
Table 2b

Clustering analysis stratified by study setting and lineages/major sub-lineage populations of MTBC.

LineageIsolates (n)
Clustered cases (c)
Clustered strains (nc)
Single cases (s)
Total strain types (s + c)
Clustering ratea (%)
UrbanRuralUrbanRuralUrbanRuralUrbanRuralUrbanRuralUrbanRural
Lineage 1344307027430411.80
Lineage 25114513341810231154.921.4
Lineage 3251204021123180
Lineage 41588153183109072568112886413845.69.8
Cameroonb96977112557510394675067247.86.5
Ghanab326503241821214438176424616
Haarlemb14412201813639831042.416.7
LAMb4376025018724744.20
Ugandab3915016023128128.20
Lineage 5274154901370137151861532.10
Lineage 61361410043093141031424.30
Summaryc210820125211113129977172122918341.79

MTBC, Mycobacterium tuberculosis complex.

The clustering rate was used to estimate the recent transmission rate.

Major lineage 4 sub-population.

The summary was calculated using only the items in cells corresponding to the six main lineages.

Within the study population, no association of recent TB transmission was found with education status, occupation, income level, ethnicity, religion, or HIV status. However, it was observed that individuals below the age of 30 years were associated with recent TB transmission, and this is similar to observations made elsewhere (Hamblion et al., 2016, Vluggen et al., 2017). Also in this study, it was observed that each year increase in age was associated with an approximately 1% (95% CI 0.13–2.00; p = 0.007) decrease in the odds of a TB patient being part of a recent transmission event, implying that compared to younger individuals, older individuals are more likely to get active TB disease by reactivation of latent TB infection rather than through a recent transmission event (Hamblion et al., 2016). This finding puts age as a risk factor for recent TB transmission in Ghana. However, this finding was largely driven by L4 and L5, since separate analysis was not valid for L6 due to the small sample size. Furthermore, it was found that the male-to-female ratio among very large clusters was significantly higher than that observed in the general TB patient population (p = 0.022). This finding, together with the observation that some large clusters involved only male subjects, also indicates that males have a higher risk of recent TB transmission compared to females, suggesting that males may engage in certain social activities that predispose them to belonging to a recent transmission event. A lower rate of multidrug-resistant TB was seen among large clustered cases compared to the general population (2% vs. 4%, p = 0.031), indicating a low multidrug-resistant TB transmissibility within the study population. This finding further suggests that the majority of drug-resistant TB cases in Ghana acquired the drug resistance during treatment, which indicates poor patient compliance (Danso et al., 2015). Moreover, it was also found that compared to drug (isoniazid and/or rifampicin)-sensitive MTBC strains, it was unlikely to find MTBC strains with isoniazid and/or rifampicin resistance involved in a recent transmission event (adjusted OR 0.7, 95% CI 0.5–0.9). Within the study setting, a reduced transmission of MAF (L5: 31.8%, L6: 24.7%) compared to MTBss L4 (44.9%) was observed. The high recent transmission rate observed for L4 was driven by both the Cameroon and Ghana sub-lineages, with no difference in their transmissibility, hence identifying these sub-lineages as very important pathogens. The high recent transmission of the Ghana sub-lineage coupled with recently reported association with drug resistance (Otchere et al., 2016) is of public health importance and hence calls for the national tuberculosis control program to support peripheral diagnostic laboratories with facilities to accurately detect and help control the spread of the Ghana sub-lineage. The higher recent transmission rate for L4 compared to L5 and L6 may not necessarily imply the outcompeting of L5 and L6 by L4, as their relative proportions remained constant over the entire study period (Figure 2) and also based on previous reports (Yeboah-Manu et al., 2016). Despite the low transmissibility of MAF, the observed stable relative proportion over the entire study period may be because the pathogen has adapted to infecting specific host populations (possibly due to unidentified host genetic or environmental factors peculiar to some West African inhabitants), hence enabling the maintenance of a stable prevalence over time. Using adjusted predictions for the probability of clustering, it was found that MAF L5 may still have the propensity to transmit equally to lineage 4 (Figure 5), not forgetting the confounding effect of a higher diversity in spoligotype pattern of L5 compared to L4 and hence reduced clustering of the former (Asante-Poku et al., 2016). Compared to L4, a significant association of L6 with individuals living in villages was found (OR 6.6, p < 0.05; Supplementary material, Table S2). The low recent TB transmission in the villages coupled with an association of L6 could be the reason why low frequencies of L6 strains were observed within the study setting. This report could be limited by the possibility of an underestimation of the recent transmission rate resulting from the misclassification of strains as unique if they were actually clustered outside of the restricted geographic sampling site and sampling period. However, measures were taken to address the underestimation of recent TB transmission by recruiting up to 90% of the diagnosed TB cases spanning a 3.5-year period. In addition, the possibility of overestimating recent TB transmission rates is also possible considering that the basis of the clustering analysis was done using combined 15-locus MIRU-VNTR typing and spoligotyping, whereas whole genome sequencing could have offered a better resolution of strains. Overall, the findings indicate high recent TB transmission, suggesting the occurrence of unsuspected outbreaks. The intensification of community education is recommended to improve early case reporting and infection control.

Funding

This research was funded by a Wellcome Trust Intermediate Fellowship Grant (097134/Z/11/Z) to Dorothy Yeboah-Manu. The funding source had no role in the study design, collection, analysis, and interpretation of the data, in the writing of the report, or in the decision to submit the paper for publication.

Ethical approval

The Scientific and Technical Committee and then the Institutional Review Board at NMIMR, University of Ghana (FWA00001824) reviewed and approved the study.

Conflict of interest

We declare that we have no competing interest.
  31 in total

Review 1.  Molecular epidemiology of tuberculosis.

Authors:  Peter F Barnes; M Donald Cave
Journal:  N Engl J Med       Date:  2003-09-18       Impact factor: 91.245

Review 2.  Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development.

Authors:  Sebastien Gagneux; Peter M Small
Journal:  Lancet Infect Dis       Date:  2007-05       Impact factor: 25.071

3.  Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing.

Authors:  Laura F Anderson; Surinder Tamne; Timothy Brown; John P Watson; Catherine Mullarkey; Dominik Zenner; Ibrahim Abubakar
Journal:  Lancet Infect Dis       Date:  2014-03-04       Impact factor: 25.071

4.  Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau.

Authors:  G Källenius; T Koivula; S Ghebremichael; S E Hoffner; R Norberg; E Svensson; F Dias; B I Marklund; S B Svenson
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis.

Authors:  Philip Supply; Caroline Allix; Sarah Lesjean; Mara Cardoso-Oelemann; Sabine Rüsch-Gerdes; Eve Willery; Evgueni Savine; Petra de Haas; Henk van Deutekom; Solvig Roring; Pablo Bifani; Natalia Kurepina; Barry Kreiswirth; Christophe Sola; Nalin Rastogi; Vincent Vatin; Maria Cristina Gutierrez; Maryse Fauville; Stefan Niemann; Robin Skuce; Kristin Kremer; Camille Locht; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

Review 6.  Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa.

Authors:  Bouke C de Jong; Martin Antonio; Sebastien Gagneux
Journal:  PLoS Negl Trop Dis       Date:  2010-09-28

7.  Diversity of Mycobacterium tuberculosis genotypes circulating in Ndola, Zambia.

Authors:  Chanda Mulenga; Isdore C Shamputa; David Mwakazanga; Nathan Kapata; Françoise Portaels; Leen Rigouts
Journal:  BMC Infect Dis       Date:  2010-06-17       Impact factor: 3.090

8.  Significance of the identification in the Horn of Africa of an exceptionally deep branching Mycobacterium tuberculosis clade.

Authors:  Yann Blouin; Yolande Hauck; Charles Soler; Michel Fabre; Rithy Vong; Céline Dehan; Géraldine Cazajous; Pierre-Laurent Massoure; Philippe Kraemer; Akinbowale Jenkins; Eric Garnotel; Christine Pourcel; Gilles Vergnaud
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

Review 9.  Effect of study design and setting on tuberculosis clustering estimates using Mycobacterial Interspersed Repetitive Units-Variable Number Tandem Repeats (MIRU-VNTR): a systematic review.

Authors:  Jessica Mears; Ibrahim Abubakar; Theodore Cohen; Timothy D McHugh; Pam Sonnenberg
Journal:  BMJ Open       Date:  2015-01-21       Impact factor: 2.692

10.  Molecular epidemiology of Mycobacterium africanum in Ghana.

Authors:  Adwoa Asante-Poku; Isaac Darko Otchere; Stephen Osei-Wusu; Esther Sarpong; Akosua Baddoo; Audrey Forson; Clement Laryea; Sonia Borrell; Frank Bonsu; Jan Hattendorf; Collins Ahorlu; Kwadwo A Koram; Sebastien Gagneux; Dorothy Yeboah-Manu
Journal:  BMC Infect Dis       Date:  2016-08-09       Impact factor: 3.090

View more
  8 in total

Review 1.  Tuberculosis caused by Mycobacterium africanum: Knowns and unknowns.

Authors:  Marta L Silva; Baltazar Cá; Nuno S Osório; Pedro N S Rodrigues; Ana Raquel Maceiras; Margarida Saraiva
Journal:  PLoS Pathog       Date:  2022-05-26       Impact factor: 7.464

2.  Analysis of Mycobacterium africanum in the last 17 years in Aragon identifies a specific location of IS6110 in Lineage 6.

Authors:  Jessica Comín; María Luisa Monforte; Sofía Samper; Isabel Otal
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.379

3.  Genotypic and phenotypic diversity of Mycobacterium tuberculosis complex genotypes prevalent in West Africa.

Authors:  Stephen Osei-Wusu; Isaac Darko Otchere; Portia Morgan; Abdul Basit Musah; Ishaque Mintah Siam; Diana Asandem; Theophilus Afum; Prince Asare; Adwoa Asante-Poku; Kwadwo Asamoah Kusi; Sebastien Gagneux; Dorothy Yeboah-Manu
Journal:  PLoS One       Date:  2021-08-26       Impact factor: 3.240

4.  Association of Mycobacterium africanum Infection with Slower Disease Progression Compared with Mycobacterium tuberculosis in Malian Patients with Tuberculosis.

Authors:  Bocar Baya; Bassirou Diarra; Seydou Diabate; Bourahima Kone; Drissa Goita; Yeya Dit Sadio Sarro; Keira Cohen; Jane L Holl; Chad J Achenbach; Mohamed Tolofoudie; Antieme Combo Georges Togo; Moumine Sanogo; Amadou Kone; Ousmane Kodio; Djeneba Dabitao; Nadie Coulibaly; Sophia Siddiqui; Samba Diop; William Bishai; Sounkalo Dao; Seydou Doumbia; Robert Leo Murphy; Souleymane Diallo; Mamoudou Maiga
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

5.  Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.

Authors:  Theophilus Afum; Prince Asare; Adwoa Asante-Poku; Isaac Darko-Otchere; Portia Abena Morgan; Edmund Bedeley; Diana Asema Asandem; Abdul Basit Musah; Ishaque Mintah Siam; Phillip Tetteh; Yaw Adusi-Poku; Rita Frimpong-Manso; Joseph Humphrey Kofi Bonney; William Ampofo; Dorothy Yeboah-Manu
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

6.  Molecular epidemiology and multidrug resistance of Mycobacterium tuberculosis complex from pulmonary tuberculosis patients in the Eastern region of Ghana.

Authors:  Benjamin D Thumamo Pokam; Dorothy Yeboah-Manu; Daniel Amiteye; Prince Asare; Prisca Wabo Guemdjom; Nchawa Yangkam Yhiler; Samuel Nii Azumah Morton; Stephen Ofori-Yirenkyi; Roger Laryea; Roger Tagoe; Anne Ebri Asuquo
Journal:  Heliyon       Date:  2021-10-09

7.  Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension.

Authors:  Boatema Ofori-Anyinam; Abi Janet Riley; Tijan Jobarteh; Ensa Gitteh; Binta Sarr; Tutty Isatou Faal-Jawara; Leen Rigouts; Madikay Senghore; Aderemi Kehinde; Nneka Onyejepu; Martin Antonio; Bouke C de Jong; Florian Gehre; Conor J Meehan
Journal:  Tuberculosis (Edinb)       Date:  2020-01-08       Impact factor: 3.131

Review 8.  The Relevance of Genomic Epidemiology for Control of Tuberculosis in West Africa.

Authors:  Prince Asare; Adwoa Asante-Poku; Stephen Osei-Wusu; Isaac Darko Otchere; Dorothy Yeboah-Manu
Journal:  Front Public Health       Date:  2021-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.